An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

Erstveröffentlichung
2010
Authors
Petzold, Axel
Chapman, Miles D.
Schraen, Susanna
Verwey, Nicolaas A.
Pasquier, Florence
et al.
Beitrag zu einer Konferenz


Published in
Experimental Neurology ; 223 (2010), 2, SI. - S. 432-438. - ISSN 0014-4886. - eISSN 1090-2430
Link to publication
https://dx.doi.org/10.1016/j.expneurol.2009.11.010
Institutions
UKU. Klinik für Neurologie
Bezirkskrankenhaus Günzburg
Sonderforschungsbereich SFB 1279 Exploting the Human Peptidome for Novel Antimicrobial and Anticancer Agents
Conference
10th International Conference on Alzheimers Disease and Related Disorders, 2006-07-15 - 2006-07-16, Madrid
Subject headings
[Free subject headings]: Cerebrospinal fluid | CSF | tau | Dementia | CEREBROSPINAL-FLUID-TAU | FRONTOTEMPORAL LOBAR DEGENERATION | MILD COGNITIVE IMPAIRMENT | BETA-AMYLOID 1-42 | BIOCHEMICAL MARKER | PHOSPHORYLATED-TAU | DIAGNOSTIC MARKER | REFERENCE VALUES | PROTEIN LEVELS
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record